Drug Facts Label Should Be Required On Immediate Package – ONP’s Ganley
This article was originally published in The Tan Sheet
Allowing the sale of OTC drugs in packages without Drug Facts labels on the immediate container poses risks for consumers, FDA Office of Nonprescription Products Director Charles Ganley says
You may also be interested in...
FDA will work cooperatively with industry to address complications that may arise from the final rule on standardized OTC labeling announced March 11, Commissioner Jane Henney, MD, told the Nonprescription Drug Manufacturers Association annual meeting in Boca Raton, Fla. March 12 (see related stories, pp. 4-10). NDMA is being renamed the Consumer Healthcare Products Association.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.
Unfounded expectation some firms have for FDA to protect their investments in preparing successful NDI notifications is part of industry’s overall interest in increased regulation of the market, says Steven Tave, Office of Dietary Supplement Programs director.